Compare NBY & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBY | VNRX |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.6M | 31.9M |
| IPO Year | 2007 | 2012 |
| Metric | NBY | VNRX |
|---|---|---|
| Price | $1.54 | $0.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 605.1K | ★ 12.0M |
| Earning Date | 03-31-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 35.42 | ★ 38.00 |
| EPS | ★ 0.76 | N/A |
| Revenue | $370,000.00 | ★ $1,233,511.00 |
| Revenue This Year | $23.91 | $68.22 |
| Revenue Next Year | $32.05 | $382.75 |
| P/E Ratio | $1.57 | ★ N/A |
| Revenue Growth | N/A | ★ 59.10 |
| 52 Week Low | $0.43 | $0.17 |
| 52 Week High | $19.95 | $0.94 |
| Indicator | NBY | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 48.03 |
| Support Level | $0.99 | $0.17 |
| Resistance Level | $1.85 | $0.27 |
| Average True Range (ATR) | 0.22 | 0.02 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 55.41 | 25.55 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.